Drugs / 13C-labeled pyruvate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05600361 | Nov 2022 → Dec 2024 | — | Chang Gung Memorial Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 13C-labeled pyruvate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05600361 ↗ |
| Modality | Diagnostic / imaging agent | “evaluate the ability of hyperpolarized 13C-labeled pyruvate from DNP MRS for detecting early treatment response” NCT05600361 ↗ |